SCHEMBL25965845

SCHEMBL25965845

Brc1cccc(N2CC3(CNC3)C2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
ALDH1A1 P00352 5/20 0.45
CYP1A2 P05177 5/20 0.45
CYP2D6 P10635 5/20 0.45
USP2 O75604 4/20 0.45
TP53 P04637 4/20 0.45
HSD17B10 Q99714 4/20 0.45
MAPK1 P28482 2/20 0.45
HIF1A Q16665 1/20 0.45
TSHR P16473 1/20 0.42
CYP3A4 P08684 4/20 0.42
CYP2C19 P33261 3/20 0.42
MGLL Q99685 1/20 0.40
ALOX5 P09917 2/20 0.39
CYP2C9 P11712 2/20 0.38
HTR3E A5X5Y0 1/20 0.38
HTR3B O95264 1/20 0.38
ADRB1 P08588 1/20 0.38
HTR1A P08908 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19690404 0.79 ALDH1A1 (0.44) MEN1KMT2AALDH1A1CYP1A2CYP2D6
SCHEMBL25966704 0.79 MEN1 (0.50) MEN1KMT2AALDH1A1CYP1A2CYP2D6
SCHEMBL24319762 0.78 TSHR (0.43) KMT2AALDH1A1CYP1A2CYP2D6USP2
SCHEMBL10111736 0.77 TSHR (0.66) ALDH1A1CYP1A2CYP2D6USP2TP53
SCHEMBL19464055 0.77 ALDH1A1 (0.47) MEN1KMT2AALDH1A1CYP1A2CYP2D6
SCHEMBL25965847 0.73 ALDH1A1 (0.53) MEN1KMT2AALDH1A1CYP1A2CYP2D6
SCHEMBL689422 0.73 HTR7 (0.62) ALDH1A1CYP1A2CYP2D6TP53CYP3A4
SCHEMBL25966709 0.72 ALDH1A1 (0.48) MEN1KMT2AALDH1A1HSD17B10MGLL
Hydrochloric Acid SCHEMBL4661519 0.71 HTR7 (0.61) ALDH1A1CYP1A2CYP2D6TP53CYP3A4
SCHEMBL5226266 0.71 MGLL (0.48) MEN1KMT2AALDH1A1TP53MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230357242-A1 COMPOUND AS AKT KINASE INHIBITOR CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD. (CN) 2023-11-09 US disclosed
EP-4223754-A1 COMPOUND AS AKT KINASE INHIBITOR CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD. (CN) 2023-08-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230357242-A1 COMPOUND AS AKT KINASE INHIBITOR AKT2, MTOR, AKT1 MEN1 1066/4885KMT2A 1901/4885ALDH1A1 4322/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.